Medicare Enrolled
Dr. Melissa Lopez-Bermejo, MD
Internal Medicine · Freedom, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lopez-Bermejo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lopez-Bermejo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lopez-Bermejo
Dr. Melissa Lopez-Bermejo is an internal medicine specialist in Freedom, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lopez-Bermejo performed 3,957 Medicare services across 1,337 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lopez-Bermejo received a total of $15,359 from 35 pharmaceutical and/or device companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lopez-Bermejo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in CA
$15,359 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,957
Medicare services
Top 8% in CA for internal medicine
1,337
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~208 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
674 | $72 | $165 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
659 | $32 | $90 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
481 | $43 | $134 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
443 | $40 | $113 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
403 | $59 | $155 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
285 | $96 | $230 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
210 | $171 | $600 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
196 | $62 | $180 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
95 | $33 | $51 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 92 | $20 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $99 | $240 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
86 | $140 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $11 | $60 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
48 | $0 | $15 |
| Annual depression screening | 25 | $21 | $40 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
23 | $90 | $240 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
23 | $76 | $200 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
22 | $237 | $515 |
| Arterial line insertion A tube is inserted into an artery through the skin to allow for blood sampling or infusion. |
21 | $36 | $115 |
| Annual alcohol misuse screening, 5 to 15 minutes | 21 | $21 | $45 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
12 | $110 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,359
Total received (2018-2024)
Avg $2,194/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
710
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,359 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,761
2023
$2,680
2022
$2,333
2021
$2,432
2020
$2,057
2019
$1,290
2018
$1,806
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,126
Boehringer Ingelheim Pharmaceuticals, Inc.
$493
Novo Nordisk Inc
$242
PFIZER INC.
$216
Mylan Specialty L.P.
$212
ABBVIE INC.
$149
Amgen Inc.
$106
GlaxoSmithKline, LLC.
$76
Lilly USA, LLC
$45
Bayer Healthcare Pharmaceuticals Inc.
$28
Novartis Pharmaceuticals Corporation
$27
Philips North America LLC
$24
Esperion Therapeutics, Inc.
$17
Top 3 companies account for 67.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,944
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,784
GlaxoSmithKline, LLC.
$1,896
Amgen Inc.
$1,857
Novo Nordisk Inc
$1,172
Janssen Pharmaceuticals, Inc
$1,088
ABBVIE INC.
$774
Mylan Specialty L.P.
$349
Lilly USA, LLC
$342
PFIZER INC.
$302
Bayer HealthCare Pharmaceuticals Inc.
$185
Amarin Pharma Inc.
$175
Abbott Laboratories
$173
Allergan Inc.
$159
Avanir Pharmaceuticals, Inc.
$142
E.R. Squibb & Sons, L.L.C.
$138
AbbVie Inc.
$127
Merck Sharp & Dohme Corporation
$95
Bayer Healthcare Pharmaceuticals Inc.
$82
Merck Sharp & Dohme LLC
$79
Novartis Pharmaceuticals Corporation
$77
Horizon Therapeutics plc
$70
Teva Pharmaceuticals USA, Inc.
$57
SANOFI-AVENTIS U.S. LLC
$52
Advanced Respiratory, Inc
$33
Dexcom, Inc.
$30
Sunovion Pharmaceuticals Inc.
$25
Daiichi Sankyo Inc.
$25
Philips North America LLC
$24
IDORSIA PHARMACEUTICALS US INC
$19
La Jolla Pharmaceutical Company
$19
Esperion Therapeutics, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$16
Eisai Inc.
$16
Allergan, Inc.
$16
Top 3 companies account for 49.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · AirDuo Digihaler · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CAMZYOS · CHANTIX · DIFICID · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GIAPREZA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · Life 2000 Ventilation System · MOUNJARO · NEXLETOL · NUCALA · NUEDEXTA · NURTEC ODT · Nuedexta · OFEV · Otezla · Ozempic · PAXLOVID · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SEEBRI · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · Utibron · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Victoza · XARELTO · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
385
Per 100K population
144.7
County median income
$109,266
Nearest hospital
WATSONVILLE COMMUNITY HOSPITAL
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lopez-Bermejo is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lopez-Bermejo experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lopez-Bermejo performed 674 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lopez-Bermejo receive payments from pharmaceutical companies?
Yes. Dr. Lopez-Bermejo received a total of $15,359 from 35 companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lopez-Bermejo's costs compare to other internal medicine physicians in Freedom?
Dr. Lopez-Bermejo's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lopez-Bermejo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Freedom
Browse internal medicine physicians in Freedom ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology